Avenue Therapeutics, Inc. (ATXI): Price and Financial Metrics
ATXI Price/Volume Stats
Current price | $1.22 | 52-week high | $15.00 |
Prev. close | $1.30 | 52-week low | $1.22 |
Day low | $1.22 | Volume | 97,700 |
Day high | $1.33 | Avg. volume | 903,780 |
50-day MA | $1.77 | Dividend yield | N/A |
200-day MA | $2.76 | Market Cap | 2.51M |
ATXI Stock Price Chart Interactive Chart >
Avenue Therapeutics, Inc. (ATXI) Company Bio
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes an intravenous formulation of tramadol HCI principally for use in the acute/intensive care hospital setting. Its product candidate is IV Tramadol for the treatment of post-operative pain. The company was founded in 2015 and is based in New York, New York.
ATXI Price Returns
1-mo | -32.65% |
3-mo | -39.00% |
6-mo | -51.20% |
1-year | -88.76% |
3-year | -99.82% |
5-year | -99.99% |
YTD | -39.00% |
2024 | -83.44% |
2023 | -86.12% |
2022 | -91.48% |
2021 | -84.74% |
2020 | -38.02% |
Loading social stream, please wait...